PDCD1LG2 and diffuse large B-cell lymphoma: Patients with TC PD-L2 positive had longer OS and PFS compared with negative patients, and patients with high expression of PD-L2 mRNA also had longer OS in two cohorts of DLBCL patients in the GEO database.